Market Briefs

Headlines

GILD
Biotech and pharma stock chart showing volatility as investors reassess sector valuations

Biotech, Pharma Stocks Draw Fresh Valuation Focus

Drug and biotech names spark volatility as rallies and discounts fuel fresh investor valuation debates.

April 2, 2026

4 min read

Gilead to buy Ouro, plan Galapagos tie-up

Gilead buys a biotech in a billion-dollar deal to secure a lead T‑cell autoimmune asset, seeks Galapagos R&D tie.

Mar 23, 2026

4 min read

Goldman’s Top Healthcare Picks Gain Fresh Catalysts

Clinical wins and analyst upgrades spark renewed momentum across big pharma and biotech stocks.

Mar 15, 2026

4 min read

Amgen and Gilead Face Conflicting Valuation Signals

Market rallies clash with valuation models as analysts and DCFs disagree on biotech pricing.

Mar 12, 2026

5 min read

Global stocks, funds and policy shifts on Feb. 21

Institutional selling hits Monster Beverage, BridgeBio; REITs, utilities post strong earnings amid policy shifts.

Feb 21, 2026

6 min read

Christmas Eve early close shapes U.S. markets

Markets brace for early close amid thin liquidity; focus on jobless claims and sector-specific trends.

Dec 24, 2025

8 min read